Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Taskus Inc (TASK) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Taskus IncTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Taskus Inc vs Health Care Select Sector SPDR Fund — how do they compare? Taskus Inc trades at $7.99 (market cap $723.41M), while Health Care Select Sector SPDR Fund trades at $168.16 (market cap $43.11B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 59.6× Taskus Inc's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Taskus Inc for 34 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

TASKXLV
Market Cap
$723.41M$43.11B
Volume
201,3038,870,090
Sector
Technology—
52-Week High
$14.69$175.68
52-Week Low
$4.57$141.95
Typical Hold Time
34 Days100 Days
Enterprise Value
$1.09B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Taskus Inc

TaskUs trades at $8.01, up 0.63% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates strong fundamentals with revenue growth to $1.18B in 2025 and net income margin expansion to 8.75%. Recent Q2 2026 earnings beat expectations with $0.33 EPS versus $0.29 expected, driven by AI services growth offsetting Trust & Safety declines.

The stock appears undervalued with P/E of 6.8 and P/S of 0.6, supported by analyst consensus target of $9.33 representing 16% upside. Key risks include labor cost pressures and client concentration, while AI segment growth at 26% provides upside catalyst. Institutional ownership increased with Dimensional Fund Advisors raising stake by 12.8% in Q1 2026.

Health Care Select Sector SPDR Fund

XLV trades at $168.81, up 1.03% with a bullish technical signal from moving averages. The healthcare ETF shows strength with 61 diversified holdings and a low 0.08% expense ratio. Recent news highlights its defensive characteristics during market volatility and potential benefits from rising interest rates. Technical indicators show support at $168 with resistance at $170, while oscillators remain neutral.

XLV offers defensive exposure to healthcare with cost efficiency, though concentration in S&P 500 stocks limits global diversification. Political uncertainty and sector-specific risks like FDA approvals present challenges, but the ETF's broad diversification and historical performance during rate hikes support a constructive outlook for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TASK

No sentiment data available yet.

XLV
53% Buy47% Sell
Avg holding period · 100 Days

About Taskus Inc

TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.

Read more on TASK →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →